Silence Therapeutics (SLN) Other Working Capital Changes (2020 - 2025)
Silence Therapeutics' Other Working Capital Changes history spans 6 years, with the latest figure at $1.7 million for Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 7354.17% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.0 million, a 291.86% decrease, with the full-year FY2025 number at $110379.0, down 75.9% from a year prior.
- Other Working Capital Changes hit $1.7 million in Q4 2025 for Silence Therapeutics, up from -$5.3 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for SLN hit a ceiling of $2.7 million in Q4 2023 and a floor of -$5.8 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$667696.0 across 5 years, with a median of $378932.5 in 2024.
- The widest YoY moves for Other Working Capital Changes: up 7354.17% in 2025, down 1560.13% in 2025.
- Tracing SLN's Other Working Capital Changes over 5 years: stood at -$3.6 million in 2021, then soared by 119.72% to $701411.1 in 2022, then skyrocketed by 287.17% to $2.7 million in 2023, then tumbled by 100.88% to -$24000.0 in 2024, then soared by 7354.17% to $1.7 million in 2025.
- Business Quant data shows Other Working Capital Changes for SLN at $1.7 million in Q4 2025, -$5.3 million in Q3 2025, and -$3.0 million in Q2 2025.